Control of T Cell Fates and Immune Tolerance by P38α Signaling in Mucosal CD103+ Dendritic Cells.

Gonghua Huang,Yanyan Wang,Hongbo Chi
DOI: https://doi.org/10.4049/jimmunol.1300398
2013-01-01
The Journal of Immunology
Abstract:Dendritic cells (DCs) play a crucial role in launching protective adaptive immunity against pathogens while maintaining immune tolerance to self-Ags. However, how intracellular signaling pathways program DCs to mediate tolerogenic responses remains largely unexplored. In this study, we describe that p38 alpha signaling in CD103(+) mesenteric lymph node DCs reciprocally regulates the differentiation of anti-inflammatory induced regulatory T cells and proinflammatory Th1 cells from naive precursors and promotes mucosal tolerance. Deficiency of p38 alpha in CD103(+) DCs inhibited the generation of induced regulatory T cells while promoting Th1 cell development in a TGF-beta 2-dependent manner. Consequently, loss of p38 alpha in DCs prevented induction of oral tolerance in vivo. Moreover, p38 alpha in CD103(+) DCs was required for optimal expression of retinaldehyde dehydrogenase, a key enzyme for retinoic acid synthesis, which in turn imprinted gut-homing receptors on responding T cells. Consistent with a crucial role of p38 alpha to program the tolerogenic activity of CD103(+) DCs, such DC subset contained constitutive activity of p38 alpha and abundant expression of TGF-beta 2 and retinaldehyde dehydrogenase. Our studies identify a key mechanism of DC-mediated coupling of T cell differentiation and trafficking that orchestrates mucosal immune tolerance.
What problem does this paper attempt to address?